TL;DR
Turn quiet afternoons into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
Researchers identified 17 plasma proteins associated with all-cause mortality in older adults, using data from a primary cohort and an independent validation cohort. Several proteins also tracked with biological-age measures, but the findings do not show that the proteins cause aging or can predict an individual’s lifespan.
A study published in Geromedicine identified 17 plasma proteins associated with all-cause mortality among older adults, with several also linked to biological-age measures across multiple organ systems. Researchers tested the findings in a second cohort, but the results show statistical associations—not that the proteins cause aging or can predict an individual’s lifespan. These findings and study details are reported in the paper, “Exploring mortality-linked proteins: Understanding their association with biological aging, disease phenotypes, signaling pathways, and their implications for longevity.”
According to the study published in Geromedicine, researchers analyzed 4,265 proteins in blood samples from 1,025 older adults enrolled in the LonGenity study. Participants were followed for an average of 8.05 years. Using Cox proportional-hazards models, the team examined how protein levels related to all-cause mortality, then assessed links with chronic disease burden and proteome-derived biological-age measures for the body as a whole and for specific organs.
The paper reports that higher levels of ERBB1 and ANTXR2 were associated with lower mortality risk and younger biological age across multiple organ systems. Higher levels of MIC-1/GDF15, HE4 and IGFBP-2 were associated with higher mortality risk and older biological age across multiple systems. The researchers also reported narrower associations: MIC-1/GDF15 tracked with older organismal biological age, while ERBB1 tracked with younger liver biological age.
The authors evaluated key findings in 1,124 participants from the Baltimore Longitudinal Study of Aging and reported that key associations were replicated in this cohort. The study was conducted by investigators from several institutions, including Albert Einstein College of Medicine and the National Institute on Aging. Its title is “Exploring mortality-linked proteins: Understanding their association with biological aging, disease phenotypes, signaling pathways, and their implications for longevity.”
How Protein Patterns Could Inform Aging Research
The study authors suggest that the results point to proteins that may help researchers study why people of similar chronological age can differ in health, disease burden and resilience. Because some mortality-associated proteins also tracked with biological-age measures in multiple organ systems, they could offer leads about the biological processes linking systemic stress, physiological balance, chronic disease and aging.
That makes the findings relevant to future research on healthy aging and longevity, but not yet to routine individual risk assessment. The paper does not provide a validated clinical test, a threshold for interpreting a person’s protein levels, or evidence that changing those levels would alter health or lifespan. The associations identify candidates for further investigation rather than a basis for medical decisions.
Popular right now
Dyson Ball Animal 3 Corded Upright Vacuum
Roborock F25 Ultra Steam Wet Dry Vacuum Mop
TCL QM64L 85-Inch QD-Mini LED 4K Smart Fire TV
As an affiliate, we earn on qualifying purchases.
Two Cohorts Tested Protein Associations
As described in the study, chronological age counts years lived, while biological-age measures aim to capture aspects of how the body—or particular organs—are aging. Such measures are research tools, and they do not necessarily correspond to a single standardized clinical definition of biological age. The investigators compared plasma-protein levels with mortality and with proteome-derived measures of biological age.
The paper reports that the work used a primary cohort from LonGenity and a separate cohort from the Baltimore Longitudinal Study of Aging to check whether key relationships appeared again in a different group of participants. It was published open access in Geromedicine in 2026. The study design can reveal patterns over time, but it cannot by itself establish why those patterns occur.
What the Associations Cannot Establish
The study does not establish that any of the identified proteins cause aging, disease or death. Protein levels may reflect underlying health conditions or biological processes rather than drive them, and observational associations cannot settle that question. The paper also does not establish that these findings can accurately estimate an individual’s risk or lifespan.
Further work is needed to clarify the mechanisms behind the associations, how well they hold across populations with different characteristics, and whether the proteins add useful information beyond existing health measures. The supplied study report does not give detailed effect sizes or clinical cutoffs for using the proteins as biomarkers, so their potential predictive value for individuals remains unclear.
Mechanisms and Clinical Use Need Testing
The study’s findings point to further research into how these proteins relate to aging pathways and disease, as well as testing the associations in additional studies. Researchers would also need to establish whether protein measurements provide reliable, meaningful risk information beyond other known indicators before any clinical application could be considered.
For now, the findings are best understood as a set of research leads. The paper does not announce a blood test or recommend changes to care based on these protein levels; whether any candidate can eventually support clinical assessment remains to be determined.
Key Questions
What did the study find?
In a study published in Geromedicine, researchers identified 17 plasma proteins associated with all-cause mortality in older adults. The paper also reports that several were associated with biological-age measures across multiple organ systems.
Which proteins were linked to lower mortality risk?
The study reports that higher levels of ERBB1 and ANTXR2 were associated with lower mortality risk and younger biological age across multiple organ systems. It does not show that raising either protein would reduce risk.
Which proteins were linked to higher mortality risk?
According to the study, higher levels of MIC-1/GDF15, HE4 and IGFBP-2 were associated with higher mortality risk and older biological age across multiple systems. These are associations, not evidence that the proteins cause those outcomes.
Can these proteins predict how long a person will live?
The study does not provide a validated test for estimating an individual’s lifespan or disease outcome. It identifies statistical associations that need further research before any clinical use can be established.
How was the research checked?
The paper reports that researchers analyzed samples from 1,025 LonGenity participants and evaluated key associations in a separate group of 1,124 Baltimore Longitudinal Study of Aging participants. The authors say key associations were independently replicated in that second cohort.
Source: news-medical.net
